(Q42722922)

5 November 2017

Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease (English)

1 reference

5 November 2017

Giuseppe Remuzzi

3

0 references

Hiddo J L Heerspink

6

object named as

Hiddo J L Heerspink

1 reference

5 November 2017

Tobias F Kröpelin

1

1 reference

5 November 2017

Dick de Zeeuw

2

1 reference

5 November 2017

Rudy Bilous

4

1 reference

5 November 2017

Hans-Henrik Parving

5

1 reference

5 November 2017

7 April 2016

1 reference

Journal of the American Society of Nephrology

5 November 2017

1 reference

5 November 2017

27

1 reference

5 November 2017

11

1 reference

5 November 2017

3405-3412

1 reference

Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View

5 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

Microalbuminuria: target for renoprotective therapy PRO.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

First morning voids are more reliable than spot urine samples to assess microalbuminuria

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

Preventing microalbuminuria in type 2 diabetes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

1 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084894

Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27056294

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27056294

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27056294

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1681/ASN.2015101150

1 reference

5 November 2017

1 reference

5 November 2017

PubMed publication ID

27056294

1 reference